ID: ALA4244211

Max Phase: Preclinical

Molecular Formula: C53H99N17O12

Molecular Weight: 1166.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C53H99N17O12/c1-27(2)22-37(62-32(11)71)47(78)67-39(24-29(5)6)49(80)69-40(25-30(7)8)50(81)68-38(23-28(3)4)48(79)64-35(18-15-21-61-53(58)59)46(77)70-42(31(9)10)51(82)65-33(16-12-13-19-54)44(75)63-34(17-14-20-60-52(56)57)45(76)66-36(43(55)74)26-41(72)73/h27-31,33-40,42H,12-26,54H2,1-11H3,(H2,55,74)(H,62,71)(H,63,75)(H,64,79)(H,65,82)(H,66,76)(H,67,78)(H,68,81)(H,69,80)(H,70,77)(H,72,73)(H4,56,57,60)(H4,58,59,61)/t33-,34-,35-,36-,37-,38-,39-,40-,42-/m0/s1

Standard InChI Key:  QFGRBFXJHAZDPE-FYEYUANWSA-N

Associated Targets(Human)

Subtilisin/kexin type 6 163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Furin 909 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

LNCaP 8286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DU-145 51482 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1166.48Molecular Weight (Monoisotopic): 1165.7659AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R..  (2018)  Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.,  61  (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144]

Source